CCDC72 Inhibitors
Chemical inhibitors of CCDC72 can regulate its activity through various cellular mechanisms. Trichostatin A, a known histone deacetylase inhibitor, can alter gene expression patterns by increasing acetylated histones. This increase can affect the transcription of genes, including those related to CCDC72, leading to changes in the protein's activity. Similarly, Staurosporine, a broad-spectrum protein kinase inhibitor, can inhibit the activity of kinases responsible for the phosphorylation of CCDC72, hence affecting its function. LY294002 and Wortmannin, both specific inhibitors of phosphoinositide 3-kinases (PI3K), can disrupt CCDC72 function by impeding the PI3K signaling pathway, which is essential for a multitude of cellular processes, including those involving CCDC72.
Further affecting the function of CCDC72, PD98059 and U0126, both inhibitors of mitogen-activated protein kinase kinase (MEK), can decrease the activation of the MAPK/ERK pathway, thereby potentially reducing the activity of CCDC72. SB203580, an inhibitor of p38 MAP kinase, can impede CCDC72 activity if it is associated with the p38 MAPK stress response pathway. Rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR) pathway, can suppress processes that regulate CCDC72 function, including cell growth and proliferation. SP600125, an inhibitor of c-Jun N-terminal kinase (JNK), can decrease CCDC72 activity if the protein is modulated by JNK signaling. ZM-447439, an Aurora kinase inhibitor, can interfere with cell cycle regulation involving CCDC72. Lastly, Bortezomib and MG132, both proteasome inhibitors, can regulate CCDC72 by preventing the proteasomal degradation of proteins that control its activity, leading to alterations in the protein's function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By inhibiting histone deacetylase, Trichostatin A causes an increase in acetylated histones, which can alter gene expression patterns. If CCDC72 is regulated by histone acetylation, Trichostatin A would inhibit its function by preventing the deacetylation of histones near the CCDC72 gene, leading to altered transcription and potentially reducing the protein's activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It inhibits a wide range of kinases by competing with ATP binding sites. If CCDC72 function is regulated by phosphorylation, staurosporine could inhibit its activity by inhibiting the kinase responsible for CCDC72 phosphorylation, thereby reducing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). If CCDC72 is involved in a pathway downstream of PI3K signaling, LY294002 would inhibit CCDC72 by blocking the PI3K pathway, which is crucial for many cellular processes such as growth and survival signals. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent inhibitor of PI3K. Similar to LY294002, if CCDC72 is part of the PI3K pathway or is regulated by it, inhibition of PI3K by wortmannin would result in decreased function of CCDC72. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is a part of the MAPK/ERK pathway. Inhibition of MEK by PD98059 would lead to decreased activation of the ERK pathway. If CCDC72 activity is dependent on the ERK pathway, inhibition by PD98059 would reduce its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. If CCDC72 function is linked to the p38 MAPK stress response pathway, inhibition by SB203580 would lead to reduced CCDC72 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR) pathway. If CCDC72 is involved in processes regulated by mTOR, such as cell growth and proliferation, rapamycin would inhibit these processes, potentially reducing the activity of CCDC72. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which are upstream regulators of ERK1/2 in the MAPK pathway. If CCDC72 is regulated by the MAPK pathway, U0126 would inhibit ERK activation, thus inhibiting CCDC72 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If CCDC72 activity is modulated by JNK signaling, inhibition of JNK by SP600125 would result in decreased function of CCDC72. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. If CCDC72 is involved in cell cycle regulation where Aurora kinases play a critical role, inhibition by ZM-447439 could lead to impaired CCDC72 function. | ||||||